You can buy or sell Globus Medical and other stocks, options, ETFs, and crypto commission-free!
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. Read More It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul in March 2003 and is headquartered in Audubon, PA.
52 Week High
52 Week Low
Simply Wall StMar 23
Globus Medical, Inc. (NYSE:GMED) Earns A Nice Return On Capital Employed
Today we are going to look at Globus Medical, Inc. (NYSE:GMED) to see whether it might be an attractive investment prospect. Specifically, we’ll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. First up, we’ll look at what ROCE is and how we calculate it. Then we’ll compare its ROCE to similar companies. Last but not least, we’ll look at what impact its current liabilities have on its ROCE...
Simply Wall StMar 14
Why Globus Medical, Inc.’s (NYSE:GMED) Cash Is A Factor You Need To Consider
Two important questions to ask before you buy Globus Medical, Inc. (NYSE:GMED) is, how it makes money and how it spends its cash. After investment, what’s left over is what belongs to you, the investor. This also determines how much the stock is worth. I will take you through Globus Medical’s cash flow health and the risk-return concept based on the stock’s cash flow yield, using the most recent financial data. This will help you think about the company from a cash perspective, which is a crucial factor to ...
Latest Trend: Globus Medical (NYSE: GMED)
Globus Medical is in the healthcare sector and is in the medical devices industry. The company CEO is David M. Demski. Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment. Previous Intraday Trading Performance: The GMED stock showed a previous change of -1.03% with an open at 46.47 and a close of 46.07. It reached an intraday high of 46....
Expected May 1, After Hours